Evidence map›Paper›PMID 28110438›Full record

ArticleNatural products and bioprospecting2017

Polysubstituted Isoflavonoids from Spatholobus suberectus, Flemingia macrophylla, and Cudrania cochinchinensis.

Li-Xia Wang, Hai-Rong Zheng, Fu-Cai Ren, Tian-Ge Chen, Xiang-Mei Li, Xian-Jun Jiang, Fei Wang

Abstract read
In one paragraph

Article in Natural products and bioprospecting, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Genome-wide analysis of the R2R3-MYB gene family inFrontiers in plant science · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li-Xia WangBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Hai-Rong ZhengBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Fu-Cai RenBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Tian-Ge ChenBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Xiang-Mei LiBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Xian-Jun JiangBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China.
Fei WangBioBioPha Co., Ltd., Kunming, 650201, People's Republic of China. f.wang@mail.biobiopha.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Four hitherto unknown polysubstituted isoflavonoids, including three isoflavans: 7,4'-dihydroxy-8,2',3'-trimethoxyisoflavan (1), 7,2',4'-trihydroxy-8,3'-dimethoxyisoflavan (2), and 7,2',4'-trihydroxy-5-methoxyisoflavan (3), and one prenylated isoflavone cudraisoflavone M (4) were isolated from the ethanol extracts of Spatholobus suberectus (for 1 and 2), Flemingia macrophylla (for 3), and Cudrania cochinchinensis (for 4), respectively. Their structures were established on the basis of extensive spectroscopic analysis. Compounds 1 and 4 exhibited weak cytotoxic activity against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480).

Indexed as

Cudrania cochinchinensisCytotoxicityFlemingia macrophyllaIsoflavanIsoflavoneSpatholobus suberectus

Identifiers

PMID28110438
PMCPMC5397389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.